PT1708987E - L-(-)-moprolol l-(+)-tartarato - Google Patents
L-(-)-moprolol l-(+)-tartarato Download PDFInfo
- Publication number
- PT1708987E PT1708987E PT05701093T PT05701093T PT1708987E PT 1708987 E PT1708987 E PT 1708987E PT 05701093 T PT05701093 T PT 05701093T PT 05701093 T PT05701093 T PT 05701093T PT 1708987 E PT1708987 E PT 1708987E
- Authority
- PT
- Portugal
- Prior art keywords
- moprolol
- tartrate
- preparing
- pharmaceutical composition
- tartrate salt
- Prior art date
Links
- 229950001994 levomoprolol Drugs 0.000 title abstract 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000145A ITMI20040145A1 (it) | 2004-01-30 | 2004-01-30 | L-moprololo lpiu' tartrato |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1708987E true PT1708987E (pt) | 2011-05-31 |
Family
ID=34835572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT05701093T PT1708987E (pt) | 2004-01-30 | 2005-01-14 | L-(-)-moprolol l-(+)-tartarato |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7524886B2 (pt) |
| EP (1) | EP1708987B1 (pt) |
| JP (1) | JP4646922B2 (pt) |
| KR (1) | KR101122173B1 (pt) |
| CN (1) | CN100480232C (pt) |
| AT (1) | ATE502003T1 (pt) |
| AU (1) | AU2005211458B2 (pt) |
| BR (1) | BRPI0507150A (pt) |
| CA (1) | CA2550302C (pt) |
| DE (1) | DE602005026908D1 (pt) |
| DK (1) | DK1708987T3 (pt) |
| EA (1) | EA200601402A1 (pt) |
| ES (1) | ES2361518T3 (pt) |
| HK (1) | HK1093962A1 (pt) |
| IL (1) | IL176280A (pt) |
| IT (1) | ITMI20040145A1 (pt) |
| PL (1) | PL1708987T3 (pt) |
| PT (1) | PT1708987E (pt) |
| SI (1) | SI1708987T1 (pt) |
| WO (1) | WO2005075408A1 (pt) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1211589A (en) * | 1968-08-06 | 1970-11-11 | Ici Ltd | Enantiomer isolation process |
| IT1113029B (it) * | 1979-03-01 | 1986-01-20 | Simes | Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro |
| IT1163107B (it) * | 1983-02-15 | 1987-04-08 | Simes | Composizioni farmaceutiche e loro uso nel trattamento del glaucoma |
| DE3544172A1 (de) * | 1985-12-13 | 1987-06-19 | Lentia Gmbh | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
| AR030414A1 (es) * | 2000-04-03 | 2003-08-20 | Astrazeneca Ab | Combinacion farmaceutica que comprende un beta bloqueante y un inhibidor de hmg-coa reductasa , formulacion farmaceutica, equipo transportable de partes , uso de esta combinacion y de esta formulacion para preparar medicamentos |
-
2004
- 2004-01-30 IT IT000145A patent/ITMI20040145A1/it unknown
-
2005
- 2005-01-14 WO PCT/EP2005/000560 patent/WO2005075408A1/en active Application Filing
- 2005-01-14 EA EA200601402A patent/EA200601402A1/ru unknown
- 2005-01-14 JP JP2006550043A patent/JP4646922B2/ja not_active Expired - Fee Related
- 2005-01-14 KR KR1020067015321A patent/KR101122173B1/ko not_active IP Right Cessation
- 2005-01-14 DK DK05701093.6T patent/DK1708987T3/da active
- 2005-01-14 AU AU2005211458A patent/AU2005211458B2/en not_active Ceased
- 2005-01-14 AT AT05701093T patent/ATE502003T1/de active
- 2005-01-14 BR BRPI0507150-0A patent/BRPI0507150A/pt not_active IP Right Cessation
- 2005-01-14 PL PL05701093T patent/PL1708987T3/pl unknown
- 2005-01-14 SI SI200531291T patent/SI1708987T1/sl unknown
- 2005-01-14 PT PT05701093T patent/PT1708987E/pt unknown
- 2005-01-14 EP EP05701093A patent/EP1708987B1/en active Active
- 2005-01-14 DE DE602005026908T patent/DE602005026908D1/de active Active
- 2005-01-14 ES ES05701093T patent/ES2361518T3/es active Active
- 2005-01-14 US US10/584,261 patent/US7524886B2/en not_active Expired - Fee Related
- 2005-01-14 CN CNB2005800023445A patent/CN100480232C/zh not_active Expired - Fee Related
- 2005-01-14 CA CA2550302A patent/CA2550302C/en not_active Expired - Fee Related
-
2006
- 2006-06-13 IL IL176280A patent/IL176280A/en not_active IP Right Cessation
- 2006-12-27 HK HK06114156.5A patent/HK1093962A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7524886B2 (en) | 2009-04-28 |
| EP1708987B1 (en) | 2011-03-16 |
| PL1708987T3 (pl) | 2011-08-31 |
| DK1708987T3 (da) | 2011-06-27 |
| IL176280A0 (en) | 2006-10-05 |
| JP2007519661A (ja) | 2007-07-19 |
| KR20070000451A (ko) | 2007-01-02 |
| AU2005211458B2 (en) | 2010-06-24 |
| DE602005026908D1 (de) | 2011-04-28 |
| EA200601402A1 (ru) | 2006-12-29 |
| HK1093962A1 (en) | 2007-03-16 |
| ES2361518T3 (es) | 2011-06-17 |
| ITMI20040145A1 (it) | 2004-04-30 |
| SI1708987T1 (sl) | 2011-06-30 |
| CA2550302A1 (en) | 2005-08-18 |
| US20080015258A1 (en) | 2008-01-17 |
| CN1910138A (zh) | 2007-02-07 |
| BRPI0507150A (pt) | 2007-06-26 |
| CA2550302C (en) | 2012-04-24 |
| CN100480232C (zh) | 2009-04-22 |
| JP4646922B2 (ja) | 2011-03-09 |
| AU2005211458A1 (en) | 2005-08-18 |
| IL176280A (en) | 2010-12-30 |
| EP1708987A1 (en) | 2006-10-11 |
| KR101122173B1 (ko) | 2012-03-15 |
| WO2005075408A1 (en) | 2005-08-18 |
| ATE502003T1 (de) | 2011-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007002189A (es) | Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos. | |
| MXPA05012678A (es) | Forma cristalina del agonista del receptor adrenergico beta2. | |
| NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
| RS20060320A (en) | Substituted indazole-o-glucosides | |
| MY142777A (en) | Substituted indole-o-glucosides | |
| UA87991C2 (en) | Substituted indole-o-glucosides | |
| HRP20041092A2 (en) | New pharmaceutical compositions containing filbanserin polymorph a | |
| BRPI0415164A (pt) | dispositivo para administrar uma composição bioterapêutica, composição bioterapêutica, método de preparação de uma composição bioterapêutica, método de tratamento, e dispensador | |
| MX2007003897A (es) | Una formulacion farmaceutica que comprende insulina cristalina e insulina disuelta. | |
| TW200505896A (en) | Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist | |
| TW200613308A (en) | Cyclobutanetetracarboxylate compound and preparation method thereof | |
| TW200638932A (en) | CCI-779 polymorph and use thereof | |
| UA83203C2 (uk) | Тіазол-(бі)циклоалкілкарбоксаніліди, засіб на їх основі та застосування для боротьби з небажаними мікроорганізмами | |
| HK1111924A1 (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient | |
| MXPA05012297A (es) | Indazol que tiene actividad analgesica. | |
| IL176280A0 (en) | L-(-)-moprolol l-(+)-tartrate | |
| HK1093721A1 (en) | Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it | |
| ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. | |
| AU2001274138A1 (en) | Propanolaminotetralines, preparation thereof and compositions containing same | |
| UA91203C2 (ru) | Новая фармацевтическая композиция, применимая для вакцин | |
| AU2003292349A1 (en) | 4-methyl-2-oxo-2h-1-benzopyran-7yl 5-thio-beta-d-xylopyranoside derivative, method for preparing same and pharmaceutical composition containing same | |
| UA11051U (uk) | Спосіб проведення анестезії | |
| UA67614A (en) | Antistress substance |